Chemours
444 hedge funds and large institutions have $2.13B invested in Chemours in 2024 Q4 according to their latest regulatory filings, with 84 funds opening new positions, 141 increasing their positions, 105 reducing their positions, and 54 closing their positions.
268% more call options, than puts
Call options by funds: $71.5M | Put options by funds: $19.4M
56% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 54
35% more capital inflows, than outflows
Capital inflows: $328M | Capital outflows: $243M
34% more repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 105
5% more funds holding
Funds holding: 423 → 444 (+21)
2.74% more ownership
Funds ownership: 81.72% → 84.46% (+2.7%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$36.3M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$17.4M |
| 3 |
AWAM
Appian Way Asset Management
New York
|
+$16.6M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$16.3M |
| 5 |
Millennium Management
New York
|
+$15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$65M |
| 2 |
Vaughan Nelson Investment Management
Houston,
Texas
|
-$44M |
| 3 |
Khrom Capital Management
Miami Beach,
Florida
|
-$22.6M |
| 4 |
Luminus Management
Houston,
Texas
|
-$19.7M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$12.1M |
CC Hedge Fund Activity: Q4 2024 in Review
444 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2024, worth a combined $2.13B — down 14% from $2.48B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new CC positions and 54 closed out — a net gain of 30 holders — while 141 added to existing stakes and 105 trimmed.
The largest buyer was UBS Group, adding an estimated $36.3M. The largest seller was Fidelity Investments, cutting an estimated $65M.
- 444 institutional investors held Chemours (CC) as of Q4 2024, up from 423 in Q3 2024.
- Funds reported $2.13B of Chemours stock for Q4 2024, down 14% quarter-over-quarter.
- 84 funds opened new Chemours positions in Q4 2024 and 54 closed out, a net change of +30 holders.
- The largest Chemours buyer in Q4 2024 was UBS Group, an estimated $36.3M added.
- The largest Chemours seller in Q4 2024 was Fidelity Investments, an estimated $65M sold.
Based on aggregated 13F filings for Q4 2024.